BetterLife Pharma, Inc. is a biotechnology company, which engages in the business of developing compounds for the treatment of mental disorders. The firm is also involved in refining and development of drug candidates from a set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company